G16D (p.Gly16Asp) variant of KRT14 (Keratin, type I cytoskeletal 14)

G16D (p.Gly16Asp) in KRT14 (Keratin, type I cytoskeletal 14) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.59 / 1. The record also includes population frequency data and structural context.

G16D (p.Gly16Asp) variant details